A parent may want to give a baby a pacifier before the injection or, if the child is nursing, breastfeed them during the injection
Adverse Reactions/Side Effects The following clinically significant adverse drug reactions are described elsewhere in the labeling: Drugs with Same Active Ingredient [see Warnings and Precautions (5.1)] Hypocalcemia and Mineral Metabolism [see Warnings and Precautions (5.2)] Renal Impairment [see Warnings and Precautions (5.3)] Osteonecrosis of the Jaw [see Warnings and Precautions (5.4)] Atypical Fractures Including Femoral Fractures [see Warnings and Precautions (5.5)] Musculoskeletal Pain [see Warnings and Precautions (5.6)] Patients with Asthma [see Warnings and Precautions (5.7)] 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice
Moreover, differences in the glycosylation pattern of recombinant proteins, which are generated via a cellular engineering process, may lead to immunogenicity
Early in the 21st century, GHR is considered to exhibit a negative effect on the process of mitochondrial biogenesis in vivo
At present, plant-active peptides with -glucosidase inhibitory activity in legumes, cereals and nuts have been studied, and the inhibition effect of different enzymatically hydrolysed protein peptides -glucosidase has been found to be significantly different
